Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster display session: Breast cancer - early stage, locally advanced & metastatic, CNS tumours, Developmental therapeutics, Genitourinary tumours - prostate & non-prostate, Palliative care, Psycho-oncology, Public health policy, Sarcoma, Supportive care

1462 - Monitoring Quality of Life in Dutch women with breast cancer: ‘the Care Notebook study’

Date

22 Oct 2018

Session

Poster display session: Breast cancer - early stage, locally advanced & metastatic, CNS tumours, Developmental therapeutics, Genitourinary tumours - prostate & non-prostate, Palliative care, Psycho-oncology, Public health policy, Sarcoma, Supportive care

Presenters

Rieneke Theresa Lugtenberg

Citation

Annals of Oncology (2018) 29 (suppl_8): viii603-viii640. 10.1093/annonc/mdy300

Authors

R.T. Lugtenberg1, M.J. Fischer2, F. de Jongh2, K. Inoue3, A. Matsuda4, S.R.S. Ramai5, J.W. Nortier1, H. Putter6, K. Yamaoka7, K. Kubota8, K. Kobayashi9, A.A. Kaptein2, J.R. Kroep1

Author affiliations

  • 1 Medical Oncology, Leiden University Medical Center (LUMC), 2300 RC - Leiden/NL
  • 2 Medical Psychology, Leiden University Medical Center (LUMC), 2300 RC - Leiden/NL
  • 3 Division Of Breast Oncology, Saitama Cancer Center, 362-0806 - Kita-adachi Ina/JP
  • 4 Hygiene And Public Health, Teikyo University School of Medicine, Tokyo/JP
  • 5 Pulmonology, Leiden University Medical Center (LUMC), 2300 RC - Leiden/NL
  • 6 Medical Statistics, Leiden University Medical Center (LUMC), 2300 RC - Leiden/NL
  • 7 Graduate School Of Public Health, Teikyo University, Tokyo/JP
  • 8 Division Of Pulmonary Medicine And Oncology, Nippon Medical School, 113-8603 - Tokyo/JP
  • 9 Respiratory Medicine, Saitama Medical University International Medical Centre, 350-1298 - Saitama/JP
More

Resources

Abstract 1462

Background

For many patients the diagnosis and treatment of cancer are associated with negative consequences for their physical, psychological and social well-being. However, patients’ needs for care cannot be addressed unless they are recognized by healthcare providers (HCP). The use of quality of life (QoL) assessments with feedback to clinicians might facilitate the discussion of QoL-items, resulting in improved QoL.

Methods

Women with stage I-IIIB breast cancer treated with chemotherapy were included in this randomised study. All respondents completed questionnaires regarding QoL, illness perceptions, self-efficacy, satisfaction with communication, and distress at three moments. Women in the experimental arm completed ‘the Care Notebook’ (CNB) questionnaire, assessing QoL, distress and care needs before every hospital visit. Results were automatically stored and presented in patients’ medical files. From the 2nd visit onwards, patients and HCPs received a copy of the latest QoL overview before the consultation. Women in the control arm received care as usual. Audio-recordings were used to investigate effects on communication and patient management.

Results

presented here are drawn from a collaborative study between Japan and the Netherlands. From July 2012 to May 2016, 60 out of 113 Dutch patients were randomized to the experimental arm. In the experimental condition, more QoL-items ‘were discussed (0.7 items each visit, p=.04), compared with the control condition, especially regarding disease-specific and psychosocial issues (p<.01). There were no differences in patient management, QoL, illness perceptions or distress. Patients in the experimental arm had higher scores on satisfaction with communication (p<.05). All patients perceived high self-efficacy in interacting with HCP. Patients in the intervention condition perceived the tool as user-friendly and a valuable addition to regular care.

Conclusions

Use of the QoL-monitor ‘The Care Notebook’ resulted in more frequent discussion of psychosocial and disease-specific issues, associated with high levels of patients’ satisfaction. However, patient management and patients’ QoL were unaffected by the intervention.

Clinical trial identification

Legal entity responsible for the study

Leiden University Medical Center.

Funding

This study was supported by a grant of the Dutch Pink Ribbon Foundation and from Pfizer, Japan.

Editorial Acknowledgement

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.